| Africa Carr, | |
|
4055 Spencer St Ste 118, Las Vegas, NV 89119-5250 | |
| (702) 799-9710 | |
| Not Available |
| Full Name | Africa Carr |
|---|---|
| Gender | Female |
| Speciality | Social Worker - Clinical |
| Location | 4055 Spencer St Ste 118, Las Vegas, Nevada |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073944070 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | IC-1679 (Nevada) | Primary |
| 225400000X | Rehabilitation Practitioner | (* (Not Available)) | Secondary |
| Entity Name | Desert Behavioral Health |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467785527 PECOS PAC ID: 3274702360 Enrollment ID: O20110805000509 |
News Archive
W. L. Gore & Associates (Gore) today announced it has received European CE Mark approval for an expanded indication of the GORE® VIABIL® Biliary Endoprosthesis that allows removal of the device up to 12 months after implantation for the treatment of benign or malignant biliary strictures. The GORE® VIABIL® Biliary Endoprosthesis first received CE Mark approval in December 1999 and U.S. Food and Drug Administration (FDA) approval in January 2002 for the treatment of biliary strictures due to malignant neoplasms.
Mylan Inc. has announced that it and/or a subsidiary have been sued in connection with four separate "first-to-file" Abbreviated New Drug Applications (ANDA) filed with the U.S. Food and Drug Administration (FDA).
Dendreon Corporation today reported results for the quarter ended June 30, 2010. Revenue for the quarter ended June 30, 2010 was $2.8 million compared to $25,000 for the quarter ended June 30, 2009. Revenue for the six months ended June 30, 2010 was $2.8 million compared to $55,000 for the six months ended June 30, 2009.
A multi-institutional team led by research faculty at Children's National in Washington, D.C., finds that extracellular vesicles (EVs) derived from kids' fat can play a pivotal role in ratcheting up risk for atherosclerotic cardiovascular disease well before any worrisome symptoms become visible.
Guidant has announced plans to conduct a study designed to increase clinical understanding of "vulnerable" plaques – lipid-rich coronary lesions that suddenly rupture – that may cause most heart attacks.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Africa Carr, 4055 Spencer St Ste 118, Las Vegas, NV 89119-5250 Ph: (702) 799-9710 | Africa Carr, 4055 Spencer St Ste 118, Las Vegas, NV 89119-5250 Ph: (702) 799-9710 |
News Archive
W. L. Gore & Associates (Gore) today announced it has received European CE Mark approval for an expanded indication of the GORE® VIABIL® Biliary Endoprosthesis that allows removal of the device up to 12 months after implantation for the treatment of benign or malignant biliary strictures. The GORE® VIABIL® Biliary Endoprosthesis first received CE Mark approval in December 1999 and U.S. Food and Drug Administration (FDA) approval in January 2002 for the treatment of biliary strictures due to malignant neoplasms.
Mylan Inc. has announced that it and/or a subsidiary have been sued in connection with four separate "first-to-file" Abbreviated New Drug Applications (ANDA) filed with the U.S. Food and Drug Administration (FDA).
Dendreon Corporation today reported results for the quarter ended June 30, 2010. Revenue for the quarter ended June 30, 2010 was $2.8 million compared to $25,000 for the quarter ended June 30, 2009. Revenue for the six months ended June 30, 2010 was $2.8 million compared to $55,000 for the six months ended June 30, 2009.
A multi-institutional team led by research faculty at Children's National in Washington, D.C., finds that extracellular vesicles (EVs) derived from kids' fat can play a pivotal role in ratcheting up risk for atherosclerotic cardiovascular disease well before any worrisome symptoms become visible.
Guidant has announced plans to conduct a study designed to increase clinical understanding of "vulnerable" plaques – lipid-rich coronary lesions that suddenly rupture – that may cause most heart attacks.
› Verified 7 days ago
Mrs. Marysol Rezanov, LCSW Clinical Social Worker Medicare: May Accept Medicare Assignments Practice Location: 4170 S Decatur Blvd Ste C1, Las Vegas, NV 89103 Phone: 702-659-8827 Fax: 702-852-0984 | |
Arthur Tabrizi, Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 6543 Las Vegas Blvd S Unit 200, Las Vegas, NV 89119 Phone: 702-933-9535 | |
Mr. David Alexander Sturgeon, CSW-INTERN Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 7381 Prairie Falcon Rd, Las Vegas, NV 89128 Phone: 702-468-1321 Fax: 702-396-0015 | |
Mrs. Pamela Rinato, LCSW, PSYD Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 3371 N Buffalo Drive, Las Vegas, NV 89129 Phone: 702-515-1374 Fax: 702-331-3098 | |
Latoyia Kurbane Griffin, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3375 S Rainbow Blvd Unit 82251, Las Vegas, NV 89180 Phone: 702-485-0430 | |
Mr. Gerald R Earl, MSSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 3131 La Canada St Ste 216, Las Vegas, NV 89109 Phone: 702-636-3000 | |
Dr. Barbara Bassong, PHD, MS, MSW, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 4700 Las Vegas Blvd N, Las Vegas, NV 89191 Phone: 702-653-2422 |